Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer
Ratika Kunder, Michelle Velyunskiy, Sara F. Dunne, Byoung-Kyu Cho, Deepak Kanojia, Lauren R. Begg, Adrienne Orriols, Erica Fleming-Trujillo, Pranathi Vadlamani, A. Vialichka, Rosemary Bolin, Jessica N Perrino, Diane J. Roth, Matthew R. Clutter, Nicolette A Zielinski-Mozny, Young Ah Goo, Massimo Cristofanilli, Marc L. Mendillo, Athanassios Vassilopoulos, Dai Horiuchi
Topics & Concepts
Triple-negative breast cancerProteasomeCancer researchBreast cancerKinaseProteasome inhibitorCancerMedicineBiologyInternal medicineCell biologyCancer Mechanisms and TherapyPeptidase Inhibition and AnalysisCancer therapeutics and mechanisms